Ricardo Spielberger
Overview
Explore the profile of Ricardo Spielberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ross J, Lee B, Ma H, Tegtmeier B, Nanayakkara D, Dickter J, et al.
Open Forum Infect Dis
. 2024 Aug;
11(8):ofae409.
PMID: 39135965
Background: Continuing antifungal prophylaxis (AFPx) to prevent invasive mold infections (IMIs) in recipients of allogeneic hematopoietic cell transplantation (alloHCT) after primary hospital discharge from alloHCT admission varies among transplant centers...
2.
Othman T, Koller P, Tsai N, Yang D, Pourhassan H, Agrawal V, et al.
Am J Hematol
. 2024 May;
99(9):1680-1690.
PMID: 38804599
Allogeneic hematopoietic cell transplantation (HCT) offers a potential cure in Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL); nonetheless, relapses are common and the major cause of mortality. One strategy to...
3.
Othman T, Li S, Zhang J, Pourhassan H, Agrawal V, Ngo D, et al.
Am J Hematol
. 2024 May;
99(8):1636-1639.
PMID: 38800943
Improved first progression-free survival following allogeneic hematopoietic cell transplantation relapse with the use of immunotherapy.
4.
Othman T, Baird J, Pak S, Mei M, Herrera A, Mansour J, et al.
Br J Haematol
. 2024 May;
205(1):368-372.
PMID: 38797530
No abstract available.
5.
Ong S, Pak S, Mei M, Wang Y, Popplewell L, Baird J, et al.
Am J Hematol
. 2023 Sep;
98(11):1751-1761.
PMID: 37668287
Fludarabine/cyclophosphamide (Flu/Cy) is established for lymphodepletion (LD) prior to standard-of-care CAR T-cell therapy for lymphoma. There is ongoing need to test alternative LD regimens to preserve efficacy, improve safety, and...
6.
Aribi A, Salhotra A, Afkhami M, Munteanu A, Ali H, Aldoss I, et al.
Leuk Lymphoma
. 2023 Aug;
64(11):1811-1821.
PMID: 37533373
We conducted a retrospective analysis of mutated acute myeloid leukemia (AML) patients who underwent allogeneic stem cell transplant. Thirty-seven patients with mutated AML were identified. Primary induction failure (40%) and...
7.
Mei M, Palmer J, Tsai N, Simpson J, OHearn J, Stein A, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Jun;
23(9):e268-e276.
PMID: 37301631
Background: Allogeneic hematopoietic stem cell transplantation (alloHCT) is potentially curative for relapsed/refractory (r/r) B-cell non-Hodgkin's lymphoma (B-cell NHL). However, relapse remains a major cause of treatment failure, especially in patients...
8.
Salhotra A, Sandhu K, Yang D, Mokhtari S, OHearn J, Tegtmeier B, et al.
Bone Marrow Transplant
. 2022 Dec;
58(3):346-348.
PMID: 36526805
No abstract available.
9.
Herrera A, Chen L, Nieto Y, Holmberg L, Johnston P, Mei M, et al.
Lancet Haematol
. 2022 Nov;
10(1):e14-e23.
PMID: 36403579
Background: After autologous haematopoietic stem-cell transplantation (HSCT), consolidation with brentuximab vedotin in patients with high-risk relapsed or refractory classic Hodgkin lymphoma has been shown to improve progression-free survival compared with...
10.
Ladbury C, Somlo G, Dagis A, Yang D, Armenian S, Song J, et al.
Transplant Cell Ther
. 2022 May;
28(7):367.e1-367.e9.
PMID: 35534000
Total body irradiation in combination with melphalan for multiple myeloma (MM) has been shown to be prohibitively toxic. To ameliorate toxicity, total marrow irradiation (TMI) has been administered as the...